PER 4.94% 8.5¢ percheron therapeutics limited

It’s not as simple as that. In the PUL 2.0 test of Capricor’s...

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    It’s not as simple as that. In the PUL 2.0 test of Capricor’s HOPE-2 trial, CAP1002 showed a decline in strength for participants over 12 months, but 65% less decline than placebo.

    At the 6 month point, the same length of ANP’s P2a trial, CAP1002 showed an average increase in strength compared to the strength of the same participants at the beginning of the trial.


    https://hotcopper.com.au/data/attachments/5538/5538547-af517e82c6152eb239a405af89a8b917.jpg





 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.004(4.94%)
Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.